Seshadri Neervannan - Net Worth and Insider Trading

Seshadri Neervannan Net Worth

The estimated net worth of Seshadri Neervannan is at least $2 Million dollars as of 2024-04-29. Seshadri Neervannan is the COO of Tarsus Pharmaceuticals Inc and owns about 64,767 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $2 Million. Details can be seen in Seshadri Neervannan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Seshadri Neervannan has not made any transactions after 2024-03-18 and currently still holds the listed stock(s).

Transaction Summary of Seshadri Neervannan

To

Seshadri Neervannan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Seshadri Neervannan owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .

Click here to see the complete history of Seshadri Neervannan’s form 4 insider trades.

Insider Ownership Summary of Seshadri Neervannan

Ticker Comapny Transaction Date Type of Owner
TARS Tarsus Pharmaceuticals Inc 2024-03-18 Chief Operating Officer

Seshadri Neervannan Latest Holdings Summary

Seshadri Neervannan currently owns a total of 1 stock. Seshadri Neervannan owns 64,767 shares of Tarsus Pharmaceuticals Inc (TARS) as of March 18, 2024, with a value of $2 Million.

Latest Holdings of Seshadri Neervannan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TARS Tarsus Pharmaceuticals Inc 2024-03-18 64,767 32.04 2,075,135

Holding Weightings of Seshadri Neervannan


Seshadri Neervannan Form 4 Trading Tracker

According to the SEC Form 4 filings, Seshadri Neervannan has made a total of 4 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the sale of 4,879 shares on March 18, 2024, which brought Seshadri Neervannan around $149,297.

Insider Trading History of Seshadri Neervannan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Seshadri Neervannan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Seshadri Neervannan Ownership Network

Ownership Network List of Seshadri Neervannan

No Data

Ownership Network Relation of Seshadri Neervannan


Seshadri Neervannan Owned Company Details

What does Tarsus Pharmaceuticals Inc do?

Who are the key executives at Tarsus Pharmaceuticals Inc?

Seshadri Neervannan is the Chief Operating Officer of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include Chief Human Resources Officer Dianne C. Whitfield , General Counsel Bryan Wahl , and Chief Commercial Officer Aziz Mottiwala .

Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary

Over the past 18 months, Seshadri Neervannan made 4 insider transaction in Tarsus Pharmaceuticals Inc (TARS) with a net sale of 7,117. Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 346,867 shares made by Bobak R. Azamian , a net sale of 31,966 shares made by Leonard M. Greenstein , and a net sale of 20,877 shares made by Aziz Mottiwala .

In summary, during the past 3 months, insiders sold 28,810 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 28,810 shares. During the past 18 months, 450,842 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 440,336 shares.

Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tarsus Pharmaceuticals Inc Insider Transactions

No Available Data

Seshadri Neervannan Mailing Address

Above is the net worth, insider trading, and ownership report for Seshadri Neervannan. You might contact Seshadri Neervannan via mailing address: 15440 Laguna Canyon Road, Suite 160, Irvine Ca 92618.

Discussions on Seshadri Neervannan

No discussions yet.